|
Volumn 41, Issue 2, 2002, Pages 265-270
|
A novel concept of reversing neuromuscular block: Chemical encapsulation of rocuronium bromide by a cyclodextrin-based synthetic host
|
Author keywords
Cyclodextrins; Drug design; Host guest systems; Medicinal chemistry; Neuromuscular blockers
|
Indexed keywords
AGENTS;
NEUROLOGY;
SURGERY;
HOST MOLECULES;
ENCAPSULATION;
CYCLODEXTRIN DERIVATIVE;
NEUROMUSCULAR BLOCKING AGENT;
ORG 25969;
ROCURONIUM;
ANDROSTANE DERIVATIVE;
CYCLODEXTRIN;
GAMMA CYCLODEXTRIN DERIVATIVE;
SUGAMMADEX;
ARTICLE;
BINDING AFFINITY;
COMPLEX FORMATION;
CRYSTAL STRUCTURE;
DRUG BINDING;
DRUG DESIGN;
ENCAPSULATION;
HUMAN;
NEUROMUSCULAR BLOCKING;
PKA;
SIDE EFFECT;
STRUCTURE ACTIVITY RELATION;
ANIMAL;
CHEMICAL STRUCTURE;
CHEMISTRY;
DIAPHRAGM;
DRUG EFFECT;
IN VITRO STUDY;
INNERVATION;
MACACA;
MOUSE;
MUSCLE CONTRACTION;
X RAY CRYSTALLOGRAPHY;
ANDROSTANOLS;
ANIMALS;
CRYSTALLOGRAPHY, X-RAY;
CYCLODEXTRINS;
DIAPHRAGM;
GAMMA-CYCLODEXTRINS;
MACACA MULATTA;
MICE;
MODELS, MOLECULAR;
MUSCLE CONTRACTION;
NEUROMUSCULAR BLOCKADE;
NEUROMUSCULAR NONDEPOLARIZING AGENTS;
|
EID: 0037127108
PISSN: 14337851
EISSN: None
Source Type: Journal
DOI: 10.1002/1521-3773(20020118)41:2<265::AID-ANIE265>3.0.CO;2-Q Document Type: Article |
Times cited : (430)
|
References (21)
|